Thomas Dürig is a results-focused R&D strategist currently serving as the Global Strategy Director for Pharma Excipients & Biopharma at Barentz. They have a strong background in pharmaceuticals, nutraceuticals, and life sciences, having held leadership positions at Ashland, Inc. and Aqualon, a Business Unit of Hercules Incorporated. Thomas has demonstrated a commitment to fostering innovation and collaboration, aligning ingredient technologies with enterprise goals to drive business results. They are pursuing a Master of Science in Pharmaceutical Sciences at the University of the Witwatersrand and have attained several diplomas in management and leadership from esteemed institutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices